Skip to main content

Table 1 Patient characteristics and clinical parameters

From: miRNAs associated with chemo-sensitivity in cell lines and in advanced bladder cancer

 

Response cohort

Survival cohort

PD

CR

SS

LS

RECIST Category

    

CR

 

8

1

7

PR

  

2

5

PD

7

 

7

1

NC

  

3

0

NE

  

2

2

In total

7

8

15

15

Age

57.7 (45-62)

56.3 (38-69)

59.3 (37-75)

58.9 (38-74)

Sex

    

Female

2

2

4

5

Male

5

6

11

10

Overall survival

4.7 (0.13-13.3)

39.8 (13.3-92.1)

5.3 (0.13-10.9)

59.7 (13.2-125.1)

  1. CR: complete response; PR: partial response; PD: progression of disease; NC: no change; NE: not estimated; SS: short survival, LS: long survival.